藥理學(xué)歷年試題七年制_第1頁
藥理學(xué)歷年試題七年制_第2頁
藥理學(xué)歷年試題七年制_第3頁
藥理學(xué)歷年試題七年制_第4頁
藥理學(xué)歷年試題七年制_第5頁
免費(fèi)預(yù)覽已結(jié)束,剩余75頁可下載查看

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

山東(2008——2009學(xué)年第二學(xué)期2006級(jí)臨床醫(yī)學(xué)七年制藥理學(xué)期末考試試題(A卷)FINALTERMEXAMNATIONOFPHARMACOLOGYFOR一、(每題2分,共10分FirstpassMedianeffectivedose,PostantibioticCellcyclespecific二、選擇題(A0.8分?X1分,50分TypeAchoicequestions(onlyoneanswerisaffinityforreceptorsbutnointrinsicnobothaffinityandintrinsicaffinityandweakintrinsicaffinityandlowhighaffinityandPD2affinitydissociationeliminationrateAdrugeliminatedwithkinetics,theconcentrationofthedrugsmais200mg/L,at10o’clockinthemorningafteradministrationofasingledose,thedrugsmaconcentrationis25mg/L,at10o’clockonsecondmorning,itst1/2A.4hB.6hC.12hD.10hE.ThedrugthatitstherapeuticindexisthelargestDrugADrugBDrugCDrugDDrugEpatientsdeveloptolerancetothepatientsdiminishtolerancetothethesensitivityofbacteriatothedrugthesensitivityofbacteriatothedrugdecreases,afterrepeatedEnoneofThemechanismoftreatingPhenobarbitalpoisoningwithbicarbonatesodiumisthatNutralizatesStimulatesPhenobarbitaltransferencefromthebraintotheBasinesurinefluids,preventPhenobarbitalfromreuptaking,andexcretionofBandCareAandCareIntheexistenceofcompetitiveantagonist,thedoseeffectcurveoftheagonistdosenotwillshifttorightparallelymovetowillbewillPatientswithmyastheniagravisaremoreeffectivelytreatedFromthefollowingindicationsfortheuseofphentolamine,whichistreatmentofhypertensioncausedbysurgicalmanipulationofdiagnosisofpheochromacytoma(嗜鉻細(xì)胞瘤primarymicrocirculationAtropinecannotbeusedtotreatpatientsneostigmineWhichoneofthefollowingdescriptionsisbRblockersdelayrecoveryofbloodglucoseafterbRblockerspromoterenninbRblockersinhibitconversionofT4tobRblockersdecreaseintraocularbRblockerscaninducereboundThedrugchoiceinthetreatmentofanaphylacticshockantihistamineAllofthefollowingstatementsabouttheactionofScolinearetrueIthasmuscleIthasganglionicblockingactionattherapeuticItpromotesthereleaseofIthasItbelongstodepolarizingneuromuscularWhichofthefollowingtherapeuticprojectscouldbeusedinthetreatmentofpatientswithorganophosphateintoxication?atropine+atropine+pralidoximeatropine+atropine+atropine+Allofthefollowingstatementsabouttheactionofphenylephrine素aretrueItisweakindecreasingrenalbloodItcanbeusedtoexamineretinaduetoitsactionofItisα1RItcanbeusedtotreatparoxysmalsupraventricularItcanbeusedtocontrolhypotensioncausedbyThereleasedneurotransmitternorepinephrineisdisposedmainlybyliverdrugCOMTinsynapticneuronalnonneuronalMAOinsynaptic onepatientis imipramineandanother theyarebothlikelytoakathisiaB.tardivedyskinesiaC.constipationanddryD.diarrhea TheoralantipsychoticdrugthatwouldbeusedforthepatientwithchronicpsychosestomaintaincurativeeffectisclozepineB.penfluridolC.D.chlorprothixeneE.toincreasetheabsorptionoftoinhibitlevodopadecarboxylationinthetoinhibitMAOD.toinhibitE.toincreaseLdopaconvertingtodopamineWhichisthedrugchoiceinthetreatmentofabsencephenytoinsodiumB.C.amobarbitalD.ethosuximideE.ThecardinalmechanismofantidepressantactionoftricyclicagentsBlockadeofNEand5HTreuptakeBlockadeofNEand5HTreuptakeStimulationofreticularascendingactivatingBlockadeof5HTreuptakeBlockadeofNEreuptakeWhichofthefollowinggesicdrugscanbeusedforpethidineB.morphineC.D.methadoneE.LithiumcarbonatecanbeusedtoParkinson’sdiseaseB.depressionC.manicD.insomniaWhichofthefollowingstatementsaboutphenytoinisnothassedativeeffectB.canbeusedforpatientswithcanbeusedtotreatpatientswithcanbeusedtomanagepatientswithtrifacialcancausegingivalhyperWhichofthefollowingdrugsis(are)hepaticmicrosomalenzymeA.rifampicinB.alcoholC.phenytoinD.phenpbarbitalE.allAspirincaninduceallofthefollowingeffectreducingfeverB.reducingprostaglandinsynthesisininflamedstimulatingrespiratorywhentakenintoxicinducingtendancytobleedingE.reducingWhichoneofthefollowingdrugsactsfromtheinnersideofthemembraneandbindmoreeffectivelytocalciumchannelsinopenstate?VerapamilB.NicorandilC.D.FlunarizineE.Whichoneofthefollowingmostdirectlydescribesthemechanismofactionofcardiacglycosides?stimulatesproductionofinhibitssodiumpotassiumdecreasestheintracellularlevelofKincreasesintracellularsodiumincreasesreleaseofcalciumfromthesarcosmicAllofthefollowingmeasurescanbeusedinthetreatmentofdigoxininducedarrhythmiaEXCEPTstopdigoxinadministrationimmediafurosemideareusedtopromotetheexcretionofpotassiumchlorideatropineThemechanismofantihypertensiveeffectoflosartandecrementofrenininhibitionofangiotensinconvertingblockadeoftheangiotensinⅡincrementofbradykinincausingvasodilationACEinhibitorscandoallofthefollowingdecreasethebloodcausingdryinhibittheformationofangiotensinpromotetheexcretionincreasebradykininconcentrationintheWhichofthefollowingantianginaldrugsisnotsuitableforpatientswithvariantangina?VerapamilB.NifedipineC.D.PropranololE.ThebestchoicetreatedforthehypertensivepatientwithheartfailureisVerapamilB.CaptoprilC.D.PrazosinE.AllofthefollowingstatementsaboutamiodaronearetrueitincreasesAPDanditsuppressesprematureventricularcontractionandventricularitblocksαanditcancausehyperorithasreverseWhichofthefollowingstatementsaboutCatoprilisItcausesreflextachycardiaItdoesnotcauselipidmetabolismIncreasingbradykininduetoitseemstoberesponsibletoItiscontraindicatedtopregnantItiscontraindicatedto lrenalarteryThedrugusefulinpreventingasthmabutlackingbronchodilatoractioniscromolynsodiumB.ephedrineC.D.labetololE.WhichofthedrugsisusedforantifibrinolysisvitKB.ridogrelC.tranexamicD.adenosineE.TheantietmechanismofaspirininhibitingsynthesisofTXA2ininhibitingsynthesisofTXA2inpromotingsynthesisofPGI2inpromotingsynthesisofPGE2inpromotingsynthesisofPGI2inThesevereadversereactionofbiguanideshypoglycemiaB.lacticacidosisC.D.blooddyscrasiasE.hepaticWhichofthefollowingstatementsaboutantiinfl actionofglucocorticoidsisNOTinhibitingboththeearlyandthelatemanifestationof inhibitingthereleaseofarachidonicaffectingalltypesof toryincreasingtheamountofInducingapoptosisof toryWhichofthefollowingmechanismsbestaccountsfortheantithyroideffectofmethylthiouracil?InhibitingperoxidaseanddecreasingthethyroxinInhibitingthethyroidInhibitingtheabsorptionofInterferingwiththeutilizationofposingtheWhichofthefollowingoralhypoglycemicagentscanbeusedindiabetesinsipidus?Glyburide(格列本脲)BMetformin(甲福明)CAcarbose(阿D.Pioglitazone(吡格列酮)E.Repaglinide(瑞格列奈Whichofthefollowingdrugscaninhibitthesynthesisofbacterialcellwall,butdoesnotbelongtoβlactamantimicrobials Whichofthefollowingdrugsisthefirstchoiceintreating smap A.tetracyclineB.azithromycinC.gentamicinD.penicillinE.kanamycinSulfonamideactsynergisticallywithtrimethoprimbecauseA.sulfonamidesinhibitthemetabolismoftrimethoprimtrimethopriminhibitthemetabolismofbothdrugsactatthesamestepininhibitingfolicacidbothdrugsactatdifferentstepsininhibitingfolicacidnoneoftheWhichofthefollowingstatementsaboutthemechanismofantibacterialdrugsismostaccurate?aminoglycosidesbindtoreceptorsonthe50sribosomalsubunittopreventattaentofaminoacyltRNAcephalosporinsinhibitthesynthesisofprecursorofthelinearpeptidoglycanchainofthecellwallfluoroquinolonesinhibitDNAdependentRNApenicillinGbindstoPBPstoinhibitthesynthesisof esofWhichofthefollowingdrugscantreatosteomyelitiscausedbyG+bacteria?penicillinGB.polymyxinC.D.clindamycinE.WhichofthefollowingdrugscanbeusedtotreatAciclovir(阿昔洛韋BzidovudineC.D.idoxuridine(碘苷)E.vidarabine(阿糖腺苷WhichofthefollowingcompatibilityadministrationispenicillinG+penicillinG+penicillinG+Awomanishospitalizedfor oniaandtreatedwithintravenousantibiotic,onthe3rdday,shedevelopedseriousdiarrhea,stoolispositiveforClostridiumdifficiletoxin.WhatisthebestA.clindamycinB.cefaclorC.metronidazoleD.erythromycinE.chloramphenicolTypeXchoicequestions(oneormoreanswersmaybePropranololcan’tbeusedinpatientsRaynaud’ssyndromeB.branchialasthmaC.D.atrioventricularblockE.Whichofthefollowingdrugscanbeusedintreatment mannitolB.timololC.D.pilocarpineE.Whichofthestatementsaboutdiazepamis(are)antianxiouseffectinasmalldoseB.sedative&hypnosisinlargerC.shorteningREMsleepD.reducingNREME.canbeusedforstatusMorphinecannauseaandvomitingB.euphoriaC.D.respiratorydepressionE.WhichofthefollowingdrugsbelongtothefirstlinedrugstherapyforhypertensioninA.AvasodilatorsuchasAcalciumchannelblockersuchasAblockersuchasAdiureticsuchasAnACEinhibitorsuchasWhichofthefollowingdrugsis(are)usefulintreatmentofventriculartachycardia?PropafenoneB.DigitoxinC.D.LidocaineE.WhichofthefollowingdrugsusedinpepticulcereradicateOmeprazoleB.sucralfateC.colloidalbismuthD.cimetidineE.sodiumWhichofthefollowingstatementaboutinsulinareitcancauseanaphylacticitcancausehyperglycemicitcanbeadministrateditsmechanismofactionisthroughintracellularreceptoritcanbeusedinIDDMandWhichis(are)theeffectiveagentagainstpseudomonasaeruginosaamongthefollowingdrugsgenetamicinB.carbenicillinC.D.ampicillinE.MetronidazolecanbeusedinthetreatmentSyphilisB.TrichomonasvaginalisC.BacterialdysenteryD.AnaerobicE.Helicobacterpylori三、問答題(共40分Pleasedescribethetreatmentofacuteorganophosphates(8PleasecomparethedifferencesbetweenchlorpromazineandNSAIDsinbodytemperatureregulation.(8points)PleasedescribethemechanismsofβAdrenoceptorblockersinthetreatmentofcongestiveheartfailure.(8points)Describetheaimandmechanismofcombineduseof 術(shù)).(8Pleasedescribetheantibacterialspectrumof(82005級(jí)臨床藥理學(xué)期末考試試題(A卷)答一、(共10分b上與藥物完全一樣的制劑Firstpasselimination:首過消除,從胃腸道吸收靜脈系統(tǒng)的藥泄的量大,除。Medianeffectivedose,ED50:半數(shù)有效量,能引起50%的實(shí)驗(yàn)動(dòng)物應(yīng)時(shí)的藥物劑量稱為半數(shù)有效量Postantibioticeffect:抗菌后效應(yīng),將細(xì)菌于濃度高于MIC某種抗繁殖不能恢復(fù)正常,這種現(xiàn)象稱為抗菌后效應(yīng)Cellcyclespecificagents:僅對(duì)細(xì)胞增殖周期中的某一期細(xì)滅作用的藥物二、題(共50分)單選(共40分) 44. 50.多選(10分 55. 三、問答題(共40分Pleasedescribethetreatmentofacuteorganophosphates答(1)消除毒物:通過皮膚,催吐減少吸收;通過洗胃,導(dǎo)促進(jìn)排泄(2分(2)應(yīng)用解物阿托品能迅速對(duì)抗體內(nèi)Ach的M樣作用如引起的流涎出汗,心率減慢等作用。應(yīng)盡量早期給藥,并根據(jù)情況采用較大劑量,達(dá)到阿托品化(3分(3)AchE藥(氯解磷定/碘解磷定:可恢復(fù)AchE活性,也可與有機(jī)磷直接結(jié)合,成為無毒的產(chǎn)物排出體外(3分PleasecomparethedifferencesbetweenchlorpromazineandNSAIDsinbodytemperatureregulation.(8答:(1)機(jī)制氯丙嗪作用于下丘腦體溫調(diào)定點(diǎn)的多巴胺受體(2分),界環(huán)境溫度的變化而變化(1分);NSAIDs通過抑制環(huán)氧酶減PGE2的成,使體溫調(diào)定點(diǎn)下調(diào)(2分),降低發(fā)熱機(jī)體的體溫(1分)(2)應(yīng)用丙嗪用于低溫麻醉和人工冬眠(1分)NSAIDs用于發(fā)熱及風(fēng)濕(1分)。PleasedescribethemechanismsofβAdrenoceptorblockersinthetreatmentofcongestiveheartfailure.(8答:交感神經(jīng)活性明顯升高、RAAS激活等神經(jīng)體液的紊亂在心衰中β-受體阻斷藥通過抗交感神經(jīng)及RAAS而治療CHF抑制交感神經(jīng)過度興奮和上調(diào)β-受體:β-受體阻斷藥通過阻斷心臟β-受體拮抗交感神經(jīng)過度興奮對(duì)心臟的損害,通過上調(diào)衰竭心臟的β-受體及恢復(fù)其信號(hào)轉(zhuǎn)導(dǎo)能力,改善其對(duì)兒茶酚胺的敏感性。(2分抑制RAAS激活:β-受體阻斷藥通過抑制RAAS激活減少腎素、心率,減少心肌耗氧,從而改善心肌缺血和心臟舒張功能。(2分抗心律失常及抗心肌缺血:能減少急性心血管及猝死的發(fā)生,改善患者預(yù)后。(2分β-受體阻斷藥對(duì)心功能的影響是雙向的短期效應(yīng)為心功能,長期用藥,明顯改善心功能與血流動(dòng)力學(xué)。(2分Describetheaimandmechanismofcombineduseoflargedoseiodineand術(shù)).(8答:甲亢術(shù)前應(yīng)服用硫脲類及大劑量碘化服用硫脲類目的:為減少在麻醉和術(shù)后的合并癥及甲狀腺危象,術(shù)前應(yīng)先服用硫脲類藥物,使甲狀腺恢復(fù)或接近正常(2分原理:硫脲類可抑制過氧化物酶,抑制甲狀腺激素的合成(2分服用大劑量碘化物的目的及原理:由于用硫脲類后負(fù)反饋性引起SH分泌增多,使腺體增生,組織脆而充血,不利于手術(shù)進(jìn)行,所以在術(shù)前周加服量碘化(2分抑制TSH使腺體增生的作腺體縮小變韌,利于手術(shù)進(jìn)行及減少(2分Pleasedescribetheantibacterialspectrumoffluoroquinolones.(8氟喹諾酮類的抗菌譜包括(1)G-菌:腸桿菌屬、假單孢菌屬、奈瑟球菌屬、桿菌屬、彎曲桿菌屬等(3分)(2分軍團(tuán)菌、衣原體、支原體、結(jié)核桿菌的、厭氧菌等(3分制作人:山東大學(xué)2010級(jí)臨七四班藥理組時(shí)間:201332日星期六【試題】山東大學(xué)/醫(yī)學(xué)院/2005級(jí)/臨床醫(yī)學(xué)七年制/藥理學(xué)試山東(2007——2008學(xué)年第二學(xué)期2005級(jí)臨床醫(yī)學(xué)七年制藥理學(xué)期末考試試題(A卷)FINALTERMEXAMNATIONOFPHARMACOLOGYFOR一、(每題2分,共10分Postantibiotic二、選擇題(A0.6分;X1分,40分TypeAchoicequestions(onlyoneanswerispA2isdissociationeliminationrateAweakbasedrugwithpKa9,ifthemediuminwhichitisdissolvedhasapH7,whatwillberatiooftheconcentrationsofionizedtounionizedformsofthebase?Whichofthefollowingisunlikelytobeassociatedwithoraldrugadministrationofanenteric-coateddosageform?irritationtothegastricmucosawithnauseaanddestructionofthedrugbygastricacidordigestiveunpleasanttasteoftheformationofnonabsorbabledrug-foodvariabilityinabsorptioncausedbyfluctuationsingastricemptyingWhichofthefollowingstatementisNOTuptake1isthemainpathwayofNAuptake2mostlyhappensinuptake1isakindofactiveWhichofthefollowinganticholines seagentsisdrugchoiceinthetreatmentofAlzheimer’sdisease?WhichofthefollowingisNOTtheindicationofpreventionofmotionWhichofthefollowingmydriasisagentsbelongstoadrenoceptorTorelieveanxietysymptoms,weusuallyWhichofthefollowingdrugsiscontraindicatedinthepatientswithAllofthefollowingproduceasignificantdecreaseinperipheralchronicadministrationofACEβ-RCalciumchannelinducedarrhythmiaEXCEPTstopdigoxindiureticagentssuchasfurosemideareusedtopromotetheexcretionofdigoxinThereasonthatdigoxincanreducetheventricularrateofatrialfibrillationpatientisDecreasingautomaticityofDecreasingautomaticityofReducingtheconductionofA-VimprovingcardiacshorteningtheeffectiverefractoryperiodWhichofthefollowingisthemostseriousmainsideeffectofstatinsandthiseffectwouldbeincreasedifastatinistakenwithciclosporin,gemfibrozilornicotinicacid?GastrointestinalElevatedbloodMigraineTheantihypertensivemechanismofdiureticsforlong-termuseincreasingwaterandsodiumexcretionfromthedecreasingsodiumconcentrationinvascularsmoothmuscleincreasingtheactivityofdecreasingtheactivityofdecreasingthesecretionofInwhichofthefollowingdrugsorthostatichypotensionoccursmostfrequentlyinfirstuse?WhichofthefollowingstatementsaboutcatoprilisinhibitingcausingdryItiscontraindicatedtopregnantpromotetheexcretionincreasebradykininconcentrationintheWhichofthefollowingdrugsisnotsuitabletotreatthepatientwithanginapectoris paniedwithasthma?isosorbideThedrugchoiceforventriculararrhythmiacausedbycardiacglycosidespoisoningissodiumWhichofthefollowingmechanismbestaccountsforthedecreasingbloodsugareffectofglibenclamide?stimulatingβ-cellinpancreaticislanddirectly,promoptingthereleaseinhibittheactivityofdecreasingtheabsorptiongofincreasethesensitivityofinsulintotargetdirectlyactivitinginsulin-Whichofthefollowingstatementsaboutthetreatmentofchronicheartfailureiswrong?patientswithevidenceoffluidretentionshouldreceiveatreatmentwithanACEinhibitorandaβ-Rblockershouldbeinitiatedandmaintainedunlessspecificallycontraindicated.digoxinmaybeaddedifneededtoreducesymptomsortoslowtheventricularresponseinpatientswithrapidatrialfibrillation.patientswithsevereheartfailureshouldalsoreceiveaβ-RspironolactonemayreducemortalityinpatientswithsevereheartA76-year-oldmalewithCHFandhearinglossisgivenadiureticaspartofaregimenthatincludesdigoxinandanACEinhibitor.Inthecourseoftreatment,hedevelopsanAVconductiondefectandisfoundtobehypomagnesemic.Shealsohasworseninghearingloss,whichisreversedwhenthedrugstopped.Whichofthefollowingdiureticsdidsheused?A70-year-oldfemaleistreatedwithsublingualnitroglycerinforheroccasionalboutsofangina.Whichofthefollowingisinvolvedintheactionofnitroglycerin?phosphodiessephosphorylationoflightchainsofcGMP56-year-oldfemalehasrecentlydevelopedessentialhypertension,forwhichsheisreceivingchlorothiazidetolowerherbloodpressure.WhichofthefollowingionswouldnotincreasingconcentrationinherA58-year-oldpatientwithahistoryofhypertensionandcongestiveheartfailureadministratingsomedrugs,nowhecominsofnausea,digoxinisstopped,whichofthefollowingdrugsalsomustbestopped?Whichofthefollowingdiseasecanbetreatedwithlargedoseofiodium?solidendemicmildTheappropriatetargetinthenephronoffurosemideNa+/K+/2Cl-cotransporteroftheluminalmembraneintheascendinglimbofHenle’sloopNa+/2Cl-cotransporteroftheluminalmembraneinthedistalcompeteswithaldosteroneforintracellularcytosmicreceptorNa+/H+exchangeroftheluminalmembraneincollectingcarbonicanhydraseofproximalBeingantagonizing5-HT3receptor,thedrugwithsignificanteffectagainstvomitingisE.VitKisasubstancetopreventorreducebleedingcausedWhichofthefollowingmechanismsbestaccountsfortheanti-thyroideffectofmethylthiouracil?inhibitingperoxidaseanddecreasingthethyroxininhibitingthethyroidinhibitingtheabsorptionofinterferingwiththeutilizationofposingtheA60-year-olddiabeticmaleistreatedwithpioglitazone.Whatisthemechanismofpioglitazone?increasedreleaseofendogenousdecreasedsmaglucagonincreasedhepaticincreasedtargettissuesensitivitytodecreasedintestinalabsorptionofWhichofthefollowingisthemostimportantapproachinpreventingpepticulcersfromrecurrence?coatingtheulcereradicatinginfectionwithH.inhibitingsecretionofgastricacidattheprotonblockingreceptoractivationofgastricacidWhichofthefollowingstatementsaboutinsulinisNOTItcancausehyperglycemicItcan’tbeadministratedItsmechanismofactionisthroughintracellularreceptorItcanbeusedinIDDMandItcancauseanaphylacticAllofthefollowingareindicationsofglucocorticoidsrheumaticpepticchildhoodacuteWhichofthefollowingstatementsaboutheparinistrueslowonsetofnoanticoagulativeeffectinpossessinganticoagulativeeffectinItcanbeadministratedTheantiasthmaticeffectofsalbutamolisattributedtoA.stimulationofβ2receptorblockadeofM-activationofguanylatecyclaseD.increaseofintracellularcGMPE.inhibitionofphosphodiesWhichofthefollowingtherapiesisthebestforapatientwithstatusaminophyllinep.o.B.hydrocortisonei.v.inhalingsodiuminhalingbeclomethasoneE.salbutamolp.o.A75-year-oldwomanishospitalizedforponiaandtreatedwithanintravenousantibiotic,onthe3rdday,shedevelopedseriousdiarrhea,stoolispositiveforClostridiumdifficiletoxin.Whatisthebesttreatment?E.A35-year-oldfemale insofitchingin lexaminationoftheurinerevealstrichomonads,whatisthepreferredtreatmentfortrachomoniasis?E.Allofthefollowingstatementsaboutantibioticsareaccuratethecephalosporinsinhibitcellwallsynthesisbyinhibitingβ-tetracyclinesinhibitproteinsynthesisofbacterialbyin ctingwiththe30sribosomalsubunit.aminoglycosidesinhibitproteinsynthesisofbacterialbyin withthe30sribosomalsubunit.polymyxinsacttodisrupttheselectivepermeabilityofbacterialcellmembranesbyinsertionintothelipidbilayer. esofWhichofthefollowingagentsisNOT cytarabine(Ara-fluorouracil(5-mercaptopurine(6-WhichofthefollowingdrugscanbeusedtotreatWhichofthefollowingantibioticsismosteffectiveagainstinfectioncausedbymethicillin-resistantstaphylococcusaureus(MRSA)?WhichofthefollowingagentsmaycausedamagetogrowingWhyisvitaminB6usuallyprescribedwithitactsasacofactorofitpreventssomeadversereactionofINHithasantituberculosisitpreventsmetabolismofitdecreasestheoccurrenceofCommonpropertiesofaminoglycosideantibioticsincludeallofthefollowingexceptpoorabsorptionafteroralextensivemetabolismindependenceonglomerularfiltrationfortheircommonlyproducecommonlyproduceA30-year-oldmalediabeticwithrenalcomplicationsdevelopsacutenephritis,P.aeruginosaisfoundinurineculturesandbloodcultures.CombinedtherapyisinstitutedwithanaminoglycosidesandwhichoftheAyoungwomanusinganoralcontraceptiveistobetreatedforpulmonarytuberculosis.SheisadvisedtouseanadditionalmethodofcontraceptionsincetheefficacyoftheoralagentiscommonlydecreasedifherdrugregimenWhichofthefollowingdrugsisthedrugchoiceinthetreatmentofseverefungalp oniaorcryptococcalmeningitis?C.a(chǎn)mphotericinBAllofthefollowingantibioticsactbyinterferingwithproteinsynthesisErythromycincannotbeusedforpatients legionella TypeXchoicequestions(oneormoreanswersmaybeWhichofthefollowingdrugsbelongtothefirst-linedrugstherapyforhypertensionincurrent?avasodilatorsuchasacardiacglycosidesuchasaβ-receptorblockersuchasathiazidediureticsuchasanACEinhibitorsuchasWhichofthefollowingis(are)nottheindicationofapreventingacuterenalcongestiveheartoliguriacausedbyWhichofthefollowingstatementsaboutamiodaroneare(is)itincreasesAPDanditblocksαandβ-itcancausepulmonaryitcancausehyper-orithasreverseuse-Whichof diabetessevere diabetesmellitusaftertheexcisionofpancreas?Whichofthefollowingstatementsaboutdicumarolis(are)true?A.VitaminKisitscompetitiveantagonistItcaninactivatecoagulantfactorⅡa,Ⅶa,Ⅸa,Itiseffectiveinvivo,notinCimetidinecanweakenitsanticoagulantItcaninhibittheaggregationofMetronidazolecanbeusedinthetreatmentBacterialHelicobacterpyloriAyoungwomanwithpregnancyshouldavoidusingwhichofthefollowingdrugstotreaturinarytractinfectioncausedbygram-negativeQuinolonescanNOTbeusedinthepatientshaveepilepsyareingrowthanddevelopmentaretakingareareallergictoWhichofthefollowingclinicalindicationsmayrequireacombinationofantibiotics?treatmentofmixedtreatmentoftreatmentofcryptococcaltreatmentoftreatmentofsevereinfectionsofunknown三、問答題(共50分Pleasedescribethepharmacologicaleffects,clinicaluses,adversereactionsandcontraindicationsofatropineinophthalmological(眼科的)diseasesaccordingtotheirinterrelationship.(10points)PleasecomparethedifferencesofgesiceffectsbetweenNSAIDsandopiodgesics.(10points)PleasedescribethepharmacologicaleffectsandclinicalusesofPleasedescribetheadverseeffectsofglucocorticoidswhentheywerelongtermusedinlargedose?(10points)PleasedescribetheadversereactionsandpreventmeasuresofpenicillinG.(102005級(jí)臨床醫(yī)學(xué)七年制藥理學(xué)期末考試試題(A卷)一、first-orderkinetics:一級(jí)消除動(dòng)力學(xué),即恒比消除,指藥物在體內(nèi)therapeuticindex:治療指數(shù),即LD50/ED50的比值ceo味上與藥物完全一樣的制劑。otaniotcectMIC或后,細(xì)菌的生長仍然受到抑制的效應(yīng)。Suerecto菌株趁機(jī)大量繁殖,引起新的,稱為二重。 多 三、問答題Pleasedescribethepharmacologicaleffects,clinicaluses,reactionsandcontraindicationsofAtropineinophthalmological

眼科的diseasesaccordingtotheirinterrelationship.(10points)藥物的藥理作用決定臨床應(yīng)用和不良反應(yīng)——2阿托品在眼科的作用擴(kuò)瞳(阻斷瞳孔/虹膜括約肌上的M受體升高眼內(nèi)壓(擴(kuò)瞳,前房;調(diào)節(jié)麻痹(阻斷睫狀肌上M受體,懸韌帶拉緊,晶狀體變扁平——每項(xiàng)基本作用各1分,解釋機(jī)制加1分,共4;驗(yàn)光配(調(diào)節(jié)麻痹作用每項(xiàng)應(yīng)用0.5對(duì)應(yīng)作用加0.5分3阿托品不良反應(yīng)及在眼科的癥眩光(括瞳(升高眼內(nèi)壓視物模糊(調(diào)節(jié)麻痹(0.5分,青光眼(升高眼內(nèi)壓(0.5分)PleasecomparethedifferencesbetweenNSAIDsand gesics(10points)(1)類鎮(zhèn)痛機(jī)制是激動(dòng)阿片受體;阿司匹林類是抑制PGS的合成(2分)(2類鎮(zhèn)痛部位主要在中樞阿司匹林類主要是在外周(2分()類鎮(zhèn)痛作用強(qiáng)大,各種類型的疼痛均有效;阿司匹林類中(2分))(4類鎮(zhèn)痛應(yīng)用多種疼痛均有效特別是幾種劇痛如、嚴(yán)重?zé)齻中g(shù)心肌梗死等引起的除鎮(zhèn)痛外一般僅(2分))(2分)類能產(chǎn)生欣和成癮性;阿司匹林類不產(chǎn)生欣和成癮性(2分)pleasedescribethepharmacologicaleffectsandclinicalusesofcalciumchannelblockersincardiovascularsystem(10points)答案鈣通道阻滯劑對(duì)心血管的作用:對(duì)心臟有負(fù)性肌力、負(fù)性頻率(3分分。鈣通道阻滯劑主要用于防治心血管疾病,如:高血壓(1分、分、預(yù)防動(dòng)脈粥樣硬化發(fā)生(1分。longtermusedinlargedose(10points)醫(yī)源性腎上腺皮質(zhì)功能亢進(jìn):物質(zhì)代謝紊亂所致(1分,具體松(1分)多毛,痤瘡(1分)高血壓,高血脂,尿糖等(1分誘發(fā)或加重(1分心血管系統(tǒng)并發(fā)癥:高血壓,動(dòng)粥(1分消化系統(tǒng)并發(fā)癥:誘發(fā)加重潰瘍(1分肌萎縮,骨質(zhì)疏松,傷口愈合遲緩(1分青光眼(1分PleasedescribetheadversereactionsofpenicillinGandhowtoprevent?(10points)答案(1)反應(yīng)(或過敏反應(yīng)包括一般反應(yīng)如:藥疹,皮炎,藥熱等(1分)嚴(yán)重:過敏性休克(1分)赫氏反應(yīng)(1分預(yù)防過敏性休克的措,①詳細(xì)詢問病史用藥史藥物過敏史 過敏史過敏史,禁用(1分前進(jìn)行皮試(1分,用藥24小時(shí)以上及更換藥物批號(hào)需重新進(jìn)行皮試(1分)③不要在沒有搶救設(shè)備和藥物的情況下使用青霉素(1分④青霉素溶液要現(xiàn)用現(xiàn)配(1分⑤一旦出現(xiàn)過敏性休上注(1分重者需同時(shí)用GCS和抗組胺藥,同時(shí)采用其他急救措施如吸氧等以防引起(1制作人:山東大學(xué)2010級(jí)臨七四班藥理組時(shí)間:201332日星期六山東(20062007學(xué)年第二學(xué)期2004床醫(yī)學(xué)七年制藥理學(xué)期末考試試題(A卷一、(A0.5分,X型每1分,50分TypeAChoicequestions(onlyoneansweris1.Adrugwitht1/23hoursisgivenintravenously,thesteadystateofsmaconcentrationcanbeexpectedA.3B.8C.10D.15E.20Whichofthefollowingistrueforadrugwhoseeliminationfromsmashowsfirstordertheofthedrugisproportionaltothedrugconcentrationintheamounteliminatedperunittimeistherateofeliminationisproportionaltothesmaeliminationinvolvesaraenzymereactionoperatingat alaplotofdrugconcentrationversustimeisastraightdrugeliminatedwithkinetics,theconcentrationofthedruginsma200mg/L,at10o’clockinthemorningafteradministrationofasingledose,thedrugsmaconcentrationis25mg/L,at10o’clockonseconddaymorning,itst1/2Aspirinisaweakacidwith4.5ofpKa,whatpercentageoflipidsolubleformwillbeinthestomachjuicewith2.5ofInthisgraph,drugsA,BandC AhasagreaterpotencythanAhasagreaterefficacythanBhaslesspotencythanAhasagreaterpotencythanBhasagreaterefficacythanWhichofthefollowingstatementsisif10mgofdrugAproducesthesameresponseas100mgofdrugB,drugAismoreefficaciousthandrugthegreatertheefficacy,thegreaterthepotencyofainselectingadrug,potencyisusuallymoreimportantthanacompetitiveantagonistincreasesvariationinresponsetoadrugamongdifferentindividualsismostlikelytooccurwithadrugshowingalargetherapeuticaweakaciddrugwithpKaofaweakbasedrugwithpKaofaweakbasedrugwithpKaofaweakaciddrugwithpKaofaweakbasedrugwithpKaofThemechanismoftreatingphenobarbitalpoisoningwithsodiumisthatstimulatesPhenobarbitaltransferencefromthebraintothealkalinizesurinefluid,preventsPhenobarbitalfromreuptake,andstimulatesexcretionofbothBandCarebothAandCareAfterrepeatedadministrationofphenobarbitalsodium,thepatientsthedrugislessuseful,thisphenomenonissideresidualTheeffectofpilocarpineoneyemiosis,increaseintraocularpressure,paralysis miosis,decreaseintraocularpressure,spasm mydriasis,increaseintraocularpressure,spasm AllofthefollowingstatementsarerelatedwithsuccinylcholinehavemusclefasciculationbeforemusclehavenoganglionicblockingactionsattherapeuticcanbeantagonizedbyelevatebloodpotassiumassistantagentsofAmalepatientisbroughttotheemergencydepartmentfollowingingestionofanunknownsubstance.Heisfoundtohaveanelevatedtemperature,hotandflushedskin,dilatedpupils,andtachycardia.Ofthefollowing,whichwouldmostlikelycausetheseApredictablydangeroussideeffectofmetoprololthatconstitutesacontraindicationtoitsclinicaluseinsusceptiblepatientsistheinductionanginaWhichofthefollowingtherapeuticprojectswouldbeusedinthetreatmentofpatientwithA.a(chǎn)tropine+norepinephrineB.a(chǎn)tropine+neostigmineD.a(chǎn)tropine+E.a(chǎn)tropine+ThereleasednorepinephrineisdisposedmainlybyA.themetabolismintheliverenzymaticreuptakebytheneuronalterminalE.MAOandCOMTintheTheelevatedbloodpressurecausedbyepinephrinemaybereversedEpinephrinemaybemixedwithcertainanesthetics,suchasprocaine,inordertostimulatelocalwoundincreasethepotencyofthelocalenhancetheirin ctionwithneuralmembranesandtheirabilitytodepressnerveretardtheirsystemicfacilitatetheirdistributionalongWhichiscorrectdescriptionabouttheβadrenoceptorbothcardiacexcitationandbronchialdilationbelongtoβ1bothcardiacexcitationandbronchialdilationbelongtoβ2bothcardiacexcitationandvasculardilationbelongtoβ1bothcardiacexcitationandvasculardilationbelongtoβ2bothvasculardilationandbronchialdilationbelongtoβ2WhichisNOTtheindicationofphentolamine?diagnosisof ualprimaryperipheralvascularocclusiveChlorpromazinecanbeusedcoronaryheartWhichofthefollowingstatementsaboutaspirinisitsgesiaisduetoinhibitionofPGitismainlyusedtorelieveheadacheandotherdullitsmainadverseeffectisGIitcaninhibititinhibitsthesynthesisofbothPGI2andExtrapyramidalsymptomscausedbychlorpromazineisdueblockingDAreceptorinmidbrainlimbicinhibitingαreceptorininhibitingDAreceptorintuberoinfunfibularinhibitingMreceptorinblockingDAreceptorinnigrostriatalThemainreasonforthecombinationuseoflevodopawithcarbidopatoincreasetheabsorptionoftoinhibitlevodopadecarboxylationinthetoinhibittoinhibittoincreaseLdopaconvertingtodopamineAthreemontholdinfantisbroughttotheemergencyroomwithseizuresoftheTonicclonictype. Hismotherreportsthattheseseizureshavebeenoccurringfor50min.ThetreatmentofchoiceWhichoneofthefollowinggesicdrugscanb

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論